AngioSafe

Surgical Instruments & Devices · Cardiovascular Devices

Overview

AngioSafe advances endovascular revascularization through the Santreva™-ATK Endovascular Revascularization Catheter and proprietary Atheroplasty™ technology, a wire-free platform for complex peripheral occlusions and CTO crossing.

Jobs

≈ $97k – $184k per year (Estimated) · In office · Full-Time · 5+ years exp · San Jose
SolidWorks
MedTech
CAPA
Apply

Growth

Hiring Momentum
41/100
Stable
Open positions
5
0 opened / 0 closed in 30 days
Median time-to-fill
46 days
faster than 29% of the market
ATS activity
Every ~5 hours
Today
Hiring Dynamics 0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Sales
50%
Finance
25% ▼
Industrial Engineering
25% ▲
Activity Timeline
Added CAPA to stack Oct 2026
New location: Washington Oct 2026
Added Microsoft Office to stack Sep 2026
New location: New York Sep 2026

Tech stack

Technologies named in job postings at AngioSafe over the last 12 months, by layer, with the share of postings for each.
Technologies in use
2
Postings analysed
2
Stack modernity
53/100
Developer tools
SolidWorks
Practices & domains
CAPA
Sign in to see how your skills match this stack Sign In

News

News modernhealthcare.com 1 year ago
FDA clearances: Karl Storz, Tandem Diabetes Care, AngioSafe
Cleared devices include two designed to support diabetes patients.
Read more
Report
Press release 1 year ago
AngioSafe Unveils Atheroplasty Innovation Following FDA 510(k) Clearance, CE Mark Approval, and First Real-World Procedures with Santreva-ATK Endovascular Revascularization Catheter
- Santreva-ATK is the world's first wire-free, external power-free, intraplaque chronic total occlusion (CTO) crossing and one-step vessel preparation platform for femoropopliteal arteries. - Atheroplasty represents a new era in endovascular revasculariza
Read more
Report
News FinanzNachrichten.de 1 year ago
AngioSafe Unveils Atheroplasty Innovation Following FDA 510(k) Clearance, CE Mark Approval, and First Real-World Procedures with Santreva-ATK Endovascular Revascularization Catheter
Santreva-ATK is the world's first wire-free, external power-free, intraplaque chronic total occlusion (CTO) crossing and one-step vessel preparation platform for femoropopliteal arteries Atheroplasty
Read more
Report

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
San Jose
San Jose United States
HQ
Connect with an Angiosafe Representative
2 open roles 2 posted in 90 days 50-200 est. staff
hires for Finance, Industrial Engineering
5215 Hellyer Avenue, Suite 240, San Jose, CA 95138
seen since Aug 2026 company site, job postings